Navigation Links
Good Start Genetics to Announce Validation Study Results for its Next-Generation DNA Sequencing Platform During an Oral Presentation at the 2011 Annual Meeting of the American Society for Reproductive Medicine (ASRM)
Date:10/12/2011

CAMBRIDGE, Mass., Oct. 12, 2011 /PRNewswire/ -- Good Start Genetics,™ Inc., an innovative molecular diagnostics company developing the new gold standard in carrier screening, today announced that it will present results from the technical validation study for its proprietary next-generation DNA sequencing platform at the Annual Meeting of the American Society for Reproductive Medicine (ASRM).  ASRM will be held from October 15-19, 2011 at the Orange County Convention Center in Orlando, Florida.  

(Photo: http://photos.prnewswire.com/prnh/20111012/NY84930LOGO )

Greg Porreca, Ph.D., a company founder and the Director of Technology, is scheduled to present the data on Tuesday, October 18th during the Procedures and Techniques – Laboratory oral discussion session that will be held from 4:00 to 6:00 p.m. The presentation (abstract #0201) is titled, "A Novel Next-Generation DNA Sequencing Test for Detection of Disease Mutations in Carrier and Affected Individuals."  

Good Start Genetics' next-generation sequencing (NGS) platform is a highly accurate, high-throughput platform that evaluates patient DNA samples and is expected to yield high detection rates regardless of ethnicity by detection of both common and novel disease-causing mutations associated with recessive genetic disorders.

Routine genetic carrier screening has traditionally employed targeted mutation analysis technologies for genotyping, which, due to cost considerations, are designed to detect only a small number of the most common disease-causing mutations that are prevalent in only specific populations.  The NGS platform developed by Good Start Genetics, however, allows for a more comprehensive determination of carrier status in routine clinical practice because it is not limited to a small targeted mutation set and, therefore, can achieve high clinical sensitivities regardless of ethnicity.  Because this platform is highly scalable, it overcomes the cost limitations of the older, first-generation Sanger technique, which although also highly accurate, has had very limited use in routine clinical practice.  

Good Start Genetics will soon be offering testing services to U.S. fertility clinics through its state-of-the-art CLIA approved lab for all genetic disorders recommended by the American Congress of Obstetricians and Gynecologists (ACOG), the American College of Medical Genetics (ACMG) and several national Jewish advocacy organizations.

The study abstracts are available online at www.asrm.org.

About Good Start Genetics

Good Start Genetics is setting the new gold standard for carrier screening in routine clinical practice by making testing for the most comprehensive set of known and novel disease-causing mutations accessible. After years of development and rigorous validation, Good Start Genetics has harnessed the power of next-generation sequencing and other best-in-class technologies to provide highly accurate, actionable, and affordable tests for all ACOG and ACMG recommended disorders. For these reasons, fertility specialists and their patients can have a high degree of confidence in their carrier screening results and no longer have to compromise accuracy for price.

These tests were developed and their performance characteristics determined by Good Start Genetics™. They have not been cleared or approved by the U.S. Food and Drug Administration. However, the laboratory is regulated under the Clinical Laboratory Improvement Amendments (CLIA) as qualified to perform high complexity clinical testing, and the tests have been analytically validated in accordance with CLIA standards.


'/>"/>
SOURCE Good Start Genetics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Hologic to Preside Over NASDAQ Opening Bell Ceremony Marking the Start of Breast Cancer Awareness Month
2. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Postherpetic Neuralgia
3. Mark Your Calendar - Open Enrollment for Medicare Prescription Drug and Health Plans Starts Earlier
4. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
5. Roche Starts Early Stage Clinical Trial in Down Syndrome
6. Prostate Cancer Awareness Month Starts in September
7. Start-Up Helps Pharma Stay on Facebook
8. meridianEMR® Customers Start Receiving Meaningful Use Incentive Payments
9. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
10. Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season
11. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , 12 februari 2016 ... een toonaangevende leverancier van productie en ontwikkeling ... industrieën, kondigt vandaag een uitbreiding aan van ... haar locatie in Charleston, SC ... geleid tot meerdere recente investeringen. ...
(Date:2/12/2016)... 2016 Indiso ltd ... ungedeckten medizinischen Bedarf bei Lungen- und Atemwegserkrankungen ... Forschungsprogramms bekannt. Das Programm, das sich mit ... respiratorischen Funktionen und anderer klinischer Parameter. ... das sich auf den ungedeckten medizinischen Bedarf ...
(Date:2/11/2016)... , Feb. 11, 2016 ... Companion Diagnostics in Personalized Medicine and Cancer Therapy. ... - High-Growth Diagnostic Testing Markets. - Key Diagnostic ... - Molecular Diagnostics in Genetic Testing. - ... Diagnostics Markets. - Over-the-Counter Diagnostic Products World Markets. ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... February 12, 2016 , ... As a former television executive, owner Tal ... and no time to decompress, Rabinowitz found herself drawn to a casual meditation class ... impact on her life, implementing a 20-minute-per-day meditation practice with her team. After her ...
(Date:2/12/2016)... Appleton, Wis. (PRWEB) , ... February 12, 2016 ... ... its second Lean Leadership Series at Zuckerberg San Francisco General Hospital on April ... to practice new behaviors and create new habits. The workshops cover a broad ...
(Date:2/12/2016)... ... 12, 2016 , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined ... Support Alliance president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System ... This will be the first Fisher House in Nevada, and will provide free ...
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist Robert LaPrade, MD, PhD ... 2016 . The list consists of physicians establishing, leading and partnering with ambulatory surgery ... , An Ambulatory Surgery Center, also known as an ASC, is a modern health ...
(Date:2/12/2016)... Ramon, CA (PRWEB) , ... February 12, 2016 , ... ... donation in northern California and Nevada, announced a partnership with San Ramon Regional Medical ... transferred to the hospital’s facilities as a way to accommodate a more certain time ...
Breaking Medicine News(10 mins):